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Objectives: To evaluate implant survival following primary total hip replacement (THR) in younger pa-
tients. To describe the diversity in use of cup-stem implant combinations.
Design: 29,558 primary THRs osteoarthritis (OA) patients younger than 55 years of age performed from
1995 through 2011 were identiﬁed using the Nordic Arthroplasty Registry Association database. We
estimated adjusted relative risk (aRR) of revision with 95% conﬁdence interval (CI) using Cox regression.
Results: In general, no difference was observed between uncemented and cemented implants in terms of
risk of any revision. Hybrid implants were associated with higher risk of any revision (aRR ¼ 1.3, CI: 1.1
e1.5). Uncemented implants led to a reduced risk of revision due to aseptic loosening (aRR ¼ 0.5, CI: 0.5
e0.6), whereas the risk was similar for hybrid and cemented implants. Compared with cemented im-
plants, both uncemented and hybrid implants led to elevated risk of revision due to other causes, as well
as elevated risk of revision due to any reason within 2 years. 183 different uncemented cup-stem implant
combinations were registered in Denmark, of these, 172 were used in less than 100 operations which is
similar to Norway, Sweden and Finland.
Conclusions: Uncemented implants perform better in relation to long-term risk of aseptic loosening,
whereas both uncemented and hybrid rather than cemented implants in patients younger than 55 years
had more short-term revisions because problems due to dislocation, periprosthetic fracture and infection
has not yet been completely solved. The vast majority of cup-stem combinations were used in very few
operations.
 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.A.B. Pedersen, Department of
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Previous literature has shown the short-term and long-term risk
of revision following primary total hip replacement (THR) to be
higher in younger than in older patients1e3. These ﬁndings could be
explained by signiﬁcant decrease in body-weight and physical ac-
tivity with age4,5. In addition, secondary osteoarthritis (OA), com-
mon indication for THR in younger patients is associated with an
elevated risk of revision during the ﬁrst 6 postoperative months1,6etd. All rights reserved.
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ﬁxation technique no difference in implant survival was found
between these two groups6. In general, most studies3,9 report an
association between uncemented ﬁxation and higher risk of revi-
sion. However, good results in terms of implant survival have been
reported for uncemented implants in younger patients in some10,11,
but not all studies12. Still, it is unknown whether the change in
design and materials over the last many years have inﬂuenced the
risk of revision of uncemented implants, which have more often
than cemented implants been subject to these changes. For
instance, metal-on-metal bearing couples, which are known to
have an increased risk of early revision13, have almost solely been
used in uncemented implants. Large between-country variation in
implants use14 has been reported previously in NARA settings. Data
from Australian hip and knee registry showed that only about 23%
of the new introduced hip and knee implants were used in more
than 100 procedures15 in total, indicating further that the intro-
duction of new implants is associated with worse outcome15,16.
As only 5% of THRs are performed in patients younger than 55
years of age, it is difﬁcult to get a sample size with adequate power
from a single center or even from a single national arthroplasty
registry. In 2007, The Nordic Arthroplasty Register Association
(NARA) was established including selected variables, which
population-based Danish, Norwegian, and Swedish hip registries
could deliver. In 2010, the Finnish Hip Register joined NARA. The
NARA database opened up new possibilities of studying the results
of prosthetic concepts on a much larger scale thanwithin any of the
national registries.
The aim of this study was to evaluate the association between
type of ﬁxation and risk of revision following primary THR in pa-
tients younger than 55 years of age using the large population-
based NARA dataset. In addition, we aimed to describe the di-
versity in use of cup-stem implant combinations.
Methods
Study settings
We conducted a population-based follow-up study, based on
data from prospective, nationwide hip arthroplasty registries in
Sweden, Norway, Denmark and Finland. These four registries
contain data on primary THRs and revisions performed in Sweden,
Norway, Denmark and Finland since 1979, 1987, 1995 and 1980,
respectively. The registries are all validated and contain more than
90% of all THRs performed in each country17e19. All orthopedic
departments in the respective countries, including private hospi-
tals, provide pre- and peri-operative data on primary THR and
revision procedures to these registries. All Swedish, Norwegian,
Danish and Finnish citizens are assigned a unique civil registration
number, permitting unambiguous linkage between hip registries
and civil registration systems in each country, enabling tracking of
patients who died, or emigrated.
The steering committees of the respective registries established
the NARA in order to combine data in one Nordic hip arthroplasty
database14.
Study population
The study included only patients younger than 55 years of age at
the time of primary THR (n ¼ 58,493). THR on patients less than 35
years of age (n ¼ 4150) were excluded due to their low number and
special reasons for requiring THR. Since previous studies found
large discrepancy related to biology, treatment and prognosis1,20
between THR patients operated due to primary and secondary
OA, we only focused on primary OA (thus n ¼ 20,769 THRs due tosecondary OA was excluded). This also enhanced the possibility of
comparing results with previous studies. Hip resurfacing pro-
cedures (n ¼ 4016) were also excluded from our study due to
prognosis which is different from the prognosis of conventional
THR21. After the exclusions, we identiﬁed 29,558 primary THRs
performed between 1 January 1995 and 31 December 2011,
including 3974 patients with bilateral surgery. Although assump-
tion about independent observations is not fulﬁlled when bilateral
observations are included in the analysis and this may theoretically
have inﬂuence on the validity of the results, we choose to do so
since this has not been shown to be a practical problem for analyses
of arthroplasty register data22,23.
Study outcome
The outcome measure was time to revision. Revision was
deﬁned as a new surgical intervention involving partial or complete
exchange or removal of the implant. Data on primary THR and
subsequent revision were accurately linked by the patient’s unique
civil registration number and the laterality of the hip registered in
the country speciﬁc hip registries. Thus, the NARA database in-
cludes information on all ﬁrst time revisions performed on the each
identiﬁed primary THR patients irrespective of laterality during the
follow-up period. We analyzed the risk of revision due to four
reasons (1) any reason, (2) aseptic loosening, (3) other causes than
aseptic loosening, and (4) any cause within 2 years of primary THR.
Statistical analyses
Age, sex, ﬁxation technique, and calendar year of primary THR
surgery were included in the analyses as possible risk factors.
Follow-up began on the day of primary THR and ended on the day of
ﬁrst revision, on the day of death, emigration, or 31 December 2011,
whichever came ﬁrst. KaplaneMeier (KM) analyses were used to
estimate the cumulative implant survival probabilities with stan-
dard error (SE) for survival. A Cox proportional hazards analysis was
used to assess the risk of revision by computing hazard ratios (HR)
as a measure of relative risks (RR) for revision with 95% Conﬁdence
Interval (CI). We compared uncemented, hybrid and inverse hybrid
implant with cemented implants as reference group during the
entire period 1995e2011 in relation to four outcomes previously
described. We repeated these analyses for each of the following
time periods,1995e1999, 2000e2003, 2004e2007 and 2008e2011.
In addition, we compared ﬁxation techniques calculating the 5
years revision risk for patients with full 5 years follow up and 10
years revision risk accordingly. Since the ﬁxation technique did not
fulﬁll the proportional hazard assumption, we split the follow-up
period into 1 year intervals. Separate sub-analyses were carried out
for sub-study population 2002e2011 (n ¼ 19,282). The reason for
doing so was to be able to account for femoral head size and
different bearing surfaces as a confounding variable, as it has only
been available in the NARA since 2002. We also presented the most
commonly used cup-stem combinations separately for each type of
ﬁxation. As for the uncemented most common cup-stem combi-
nations, we included those used in more than 3% of patients
receiving uncemented implants. The corresponding percentage for
other types of ﬁxation was 4%. All analyses were performed using
SAS version 9.1.3. (SAS Institute Inc, Cary, NC).
Results
Description of study population
Characteristics of the study population 1995e2011 are pre-
sented in Table I, including the distribution of causes for revision
Table I
Characteristics of the study population 1995e2011
Characteristics All patients
n ¼ 29,558
Sex Female 14,167 (47.9%)
Male 15,391 (52.1%)
Age, years 35e45 4078 (13.8%)
46e55 25,480 (86.2%)
Year of primary THR surgery 1995e1999 6690 (22.6%)
2000e2003 6735 (22.8%)
2004e2007 7123 (24.1%)
2008e2011 9010 (30.5%)
Fixation technique Cemented 6824 (23.1%)
Uncemented 16,407 (55.5%)
Hybrid 3068 (10.4%)
Inverse hybrid 3259 (11.0%)
Distribution of causes of
revision during the entire
follow-up period (n ¼ 2413)
Aseptic loosening 1290 (53.4%)
Unspeciﬁed 415 (17.2%)
Dislocation 288 (11.9%)
Deep infection 219 (9.1%)
Periprosthetic fracture 91 (3.8%)
Pain only 78 (3.2%)
Distribution of causes of
revision within 2 years of
follow-up period (n ¼ 590)
Dislocation 150 (25.4%)
Aseptic loosening 136 (23.0%)
Deep infection 119 (20.2%)
Unspeciﬁed 105 (17.8%)
Periprosthetic fracture 52 (8.8%)
Pain only 28 (4.7%)
Fig. 1. A. KM survival according to ﬁxation technique and any revision as an endpoint. B. K
endpoint. C. KM survival according to ﬁxation technique and revision due to other causes tha
revision due to any cause within 2 years of primary surgery as an endpoint.
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aseptic loosening, followed by unspeciﬁed causes and dislocation),
as well as within 2 years of primary THR (most common cause was
dislocation, followed by aseptic loosening and deep infection).
During the entire follow-up period, 8.2% (2413) of the primary THRs
were revised due to any reason, whereas 4.4% (1290) and 3.8%
(1123) were revised due to aseptic loosening and due to other
reasons than aseptic loosening, respectively. 2.0% (590) of primary
THRs were revised within the ﬁrst 2 years due to any reason
(Table I).
Sub-study population 2002e2011 comprise of the following
femoral head size:28mm (55%), 28e36mm (29%),>36mm (19%)
and missing data (1%). About 60% of uncemented and 11% of
cemented implants were inserted with femoral head size 28 mm.
In total, following bearing surfaces were used: Metal-on-metal
(14%), Metal-on-poly (45%), Ceramic-on-poly (20%), other surfaces
(13%) and missing data (8%). For uncemented implants, the distri-
bution was as following: 18%, 36%, 16% and 17%, whereas for
cemented was 2%, 71%, 21% and 2%.
Fixation technique
During the entire study period of 1995e2011, we found nomajor
difference between uncemented and cemented ﬁxation in terms of
risk of any revision (Fig. 1(A)). However, we found that uncemented
implants were associated with a reduced risk of revision due to
aseptic loosening (RR ¼ 0.5, CI: 0.5e0.6), but an elevated risk ofM survival according to ﬁxation technique and revision due to aseptic loosening as an
n aseptic loosening as an endpoint. D. KM survival according to ﬁxation technique and
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3.2) compared to cemented implants (Table II) (Fig. 1(B,C)). In
addition, risk of revision due to any cause within 2 years of surgery
was almost twice as high for uncemented compared to cemented
implants (RR ¼ 1.8, CI: 1.4e2.3) (Fig. 1(D)). Hybrid ﬁxation tech-
nique was associated with 34% (CI: 1.2e1.5) higher risk of any
revision compared with the cemented technique during the period
1995e2011. No difference was observed between hybrid and
cemented implants in relation to revision due to aseptic loosening,
but hybrid implants led to an increased risk of revision of 2.1 (CI:
1.7e2.6) due to other causes than aseptic loosening compared with
cemented implants (Table II). In addition, hybrid implants led to
65% higher risk of revision due to any cause within 2 years of sur-
gery compared with cemented implants (CI: 1.2e2.3). We observed
a tendency towards lower risk of any revision and revision due to
aseptic loosening for inverse hybrid implants compared with
cemented implants, but higher risk of other revisions (Table II).
The estimates did not differ between female and males, either
between age groups 35e45 and 46e55 years of age.
Adjustment for the femoral head size and bearing surfaces, in
addition to age, gender and calendar year of surgery in the separate
analyses for the patients operated between 2002 and 2011 weak-
ened the associations, but did not change substantially risk esti-
mates when comparing ﬁxation technique in relation to different
revision outcomes (data not shown).
Supplementary appendix Table 1 present by gender and age
groups the adjusted RR estimates with 95% CI for uncemented,
hybrid and inverse hybrid implant with cemented implant as the
reference group. The estimates did not deviate from the overall
estimates for ﬁxation techniques.
Fixation technique e time trend analyses
Results regarding ﬁxation technique varied slightly through the
four time periods. No difference was seen in the risk of any revision
between uncemented and cemented implants when analyzing the
data separately for each of the four different time periods
[Fig. 2(A)]. Lower risk of revision due to aseptic loosening, increased
risk of revision due to other causes than aseptic loosening, and
increased risk of revision due to any causewithin 2 years of primary
surgery for uncemented compared with cemented implants was
only evident in the periods 1995e1999, 2000e2003, 2004e2007,
but not in the period 2008e2011 [Fig. 2(BeD)]. Comparing hybrid
with cemented implants, any risk of revision was higher for hybrid
implants in patients operated in the time periods 1995e1999
(RR¼ 1.3, CI: 1.1e1.5), 2000e2003 (RR¼ 1.3, CI: 1.0e1.7) and 2004e
2007 (RR ¼ 2.1, CI: 1.3e3.3), whereas it decreased in the period
2008e2011 (RR ¼ 0.6, CI: 0.2e1.7) [Fig. 2(A)].
We presented crude KM survival data after 2, 10 and 16 years for
different implants in relation to any revision, revision due to aseptic
loosening and revision due to other causes than aseptic loosening
in Table III. Supplementary appendix Table 2 present RR estimatesTable II
Risk of revision according to ﬁxation technique. n ¼ number of revisions (%) among all p
Fixation technique Any revision Revision aseptic
n (%) HR (95% CI)* n (%)
Overall Cemented 692 (10.1%) 1.0 (ref.) 526 (7.7%)
Uncemented 1139 (6.9%) 1.0 (1.0e1.2) 403 (2.5%)
Hybrid 47 4 (15.4%) 1.3 (1.2e1.5) 307 (10.0%)
Inverse hybrid 108 (3.3%) 0.8 (0.7e1.0) 54 (1.7%)
* HR with 95% CI, mutually adjusted for gender, age, year of surgery.
y Revision other causes includes all revisions except revisions due to aseptic looseninfor ﬁxation technique according to follow-up period divided into 1
year intervals, indicating the same pattern regarding risk for re-
visions as observed in the four time periods.
Additional analyses of the 5 year and 10 years risk of any revi-
sion, revision due to aseptic loosening and revision due to other
causes than aseptic loosening among patients with complete 5 and
10 years follow up are presented in Table IV. Again, uncemented
implants had the same or increased risk of any revision compared
with cemented implants, reduced risk of revision due to aseptic
loosening and increased risk of revision due to other causes. Revi-
sion risk for hybrid and inverse hybrid implants compared with
cemented has not changed substantially from the estimates pre-
sented in Table II.
Implant brands
Four types of uncemented implants were accounting for 30% of
all uncemented THRs (thus, 3675 patients received the four most
common uncemented implants, whereas 11,021 patients received
other uncemented implants) (Table V). Likewise, 4041 (61%), 720
(27%) and 1043 (36%) patients received the four most common
cemented, hybrid and inverse hybrid cup-stem implants, respec-
tively. During the entire study period 1995e2011, 183 different
uncemented cup-stem combinations were registered in Denmark
and 94% were used in less than 100 operations. Similarly, in Nor-
way, Sweden and Finland, 95%, 91%, and 94% uncemented combi-
nations were used in less than 100 operations during the entire
study period. The similar picture was seen for cemented cup-stem
combinations in all four countries.
60 combinations were used in less than 100 operations. Like-
wise, in Norway, Sweden and Finland, 65 out of 69, 95 out of 106,
and 73 out of 74 cemented combinations were used in less than 100
operations during the entire study period.
Discussion
Study population
More than half of our study population received uncemented
implants, with between-countries variations from 37% to 84%. This
is in agreement with the latest review of annual report data from
seven international hip replacement registries, showing a current
prevalence of uncemented implants among all THR patients of
between 15% and 82%24. Uncemented implants, in particular the
modern second-generation type, have been the ﬁrst choice of
implant for younger patients, whereas cemented implants were
more commonly used in older patients25e29. Some countries,
however, including Australia, Denmark, Finland and Canada pre-
dominantly use uncemented implants irrespective of patient
age25,28,30. The increase in use of uncemented implants has been
reported in all age groups, including older patients, despite reports
showing that survival of cemented implants is clearly better thanrimary THR operations in each category
loosening Revision other causesy Revision due to any cause
within 2 years
HR (95% CI) n (%) HR (95% CI) n (%) HR (95% CI)
1.0 (ref.) 166 (2.4%) 1.0 (ref.) 92 (1.3%) 1.0 (ref.)
0.5 (0.5e0.6) 736 (4.5%) 2.6 (2.2e3.1) 379 (2.3%) 1.8 (1.4e2.3)
1.1 (0.9e1.3) 167 (5.4%) 2.1 (1.7e2.6) 68 (2.2%) 1.7 (1.2e2.3)
0.8 (0.6e1.0) 54 (1.7%) 1.3 (1.0e1.8) 51 (1.6%) 1.2 (0.8e1.7)
g during the entire follow-up period.
Fig. 2. A: Association between ﬁxation technique and risk of any revision, time trend analyses. HR with 95% CI adjusted for sex and age. Reference: Cemented implants. B: As-
sociation between ﬁxation technique and risk of revision due to aseptic loosening, time trend analyses. HR with 95% CI adjusted for sex and age. Reference: Cemented implants. C:
Association between ﬁxation technique and risk of revision due to other causes, time trend analyses. HR with 95% CI adjusted for sex and age. Reference: Cemented implants. D:
Association between ﬁxation technique and risk of any revision within 2 years of surgery, time trend analyses. HR with 95% CI adjusted for sex and age. Reference: Cemented
implants.
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and patients older than 65 years of age31. The recommendation on
use of ﬁxation technique should be further guided by the mortality
risk which was found to be different between cemented and
uncemented implants32.
Fixation technique
Our analyses show that the risk of any revision related to
uncemented implants was comparable to that of cemented im-
plants, which conﬁrms the recent ﬁndings from several registriesTable III
Unadjusted KM survival at 2, 10 and 16 years according ﬁxation technique and different
Fixation technique 2 years follow up
Survival
Any revision Cemented 98.6%
Uncemented 97.5%
Hybrid 97.7%
Inverse hybrid 98.3%
Revision Aseptic loosening Cemented 99.6%
Uncemented 99.5%
Hybrid 99.3%
Inverse hybrid 99.5%
Revision other causes Cemented 99.0%
Uncemented 98.0%
Hybrid 98.4%
Inverse hybrid 98.7%including those of New Zealand, Sweden, Finland, England, Norway
and Denmark11,12,26,28,33,34. Some of the uncemented implants
introduced in Norway before 2000 were found to have higher
overall risk of revision than cemented implants33 and were
consequently removed from the market. A systematic review and
meta-analysis of nine randomized trials, including a total of 930
THRs with a mean age of 60 years also conﬁrmed that there is no
major difference between uncemented and cemented implants in
relation to risk of any revision35. Results from the Australian Hip
Registry36 show also no difference between uncemented and
cemented implants in relation to any revision, which change tooutcomes following primary THR operations 1995e2011
10 years follow up 16 years follow up
SE Survival SE Survival SE
0.14 90.2% 0.43 77.4% 1.13
0.13 90.2% 0.35 75.6% 1.42
0.27 86.6% 0.69 68.5% 2.12
0.24 92.2% 1.01 79.8% 7.22
0.43 92.8% 0.38 80.5% 1.13
0.06 96.2% 0.24 89.0% 1.03
0.15 91.4% 0.59 75.9% 2.17
0.13 94.4% 0.97 87.7% 5.52
0.12 97.3% 0.23 96.1% 0.39
0.11 93.7% 0.28 85.0% 1.26
0.23 94.8% 0.44 90.1% 1.08
0.21 97.6% 0.41 91.0% 5.91
Table IV
Five and 10 years risk of revision by ﬁxation techniques for among patients with complete 5 years follow up and those with complete 10 years follow up
Calendar year Fixation technique HR (95%-CI) any
revision 5 years
HR (95%-CI) aseptic
loosening 5 years
HR (95%-CI) other
causes 5 years
HR (95%-CI) any
revision 10 years
HR (95%-CI) aseptic
loosening 10 years
HR (95%-CI) other
causes 10 years
1995e2001 Cemented 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
Uncemented 1.22 (0.97e1.54) 0.57 (0.40e0.82) 2.29 (1.63e3.21) 1.07 (0.93e1.23) 0.55 (0.45e0.66) 2.74 (2.14e3.51)
Hybrid 1.68 (1.30e2.17) 1.16 (0.80e1.66) 2.53 (1.73e3.70) 1.42 (1.21e1.67) 1.16 (0.95e1.40) 2.28 (1.70e3.05)
Inverse hybrid 0.88 (0.43e1.81) 0.35 (0.09e1.44) 1.76 (0.75e4.12) 0.68 (0.42e1.09) 0.59 (0.33e1.06) 0.96 (0.42e2.21)
1995e2006 Cemented 1.00 (reference) 1.00 (reference) 1.00 (reference) e e e
Uncemented 1.35 (1.13e1.61) 0.64 (0.48e0.84) 2.22 (1.74e2.84) e e e
Hybrid 1.74 (1.40e2.16) 1.30 (0.94e1.79) 2.28 (1.68e3.09) e e e
Inverse hybrid 1.01 (0.73e1.41) 0.72 (0.43e1.21) 1.37 (0.88e2.13) e e e
HR adjusted for age and gender.
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exclusion of large head size. Adjusting for head size, we were not
able to achieve the same results. Uncemented implants were
introduced in order to solve the problem of aseptic loosening of
cemented implants37 as well as wear of the acetabular bearing
side38, particularly in younger patients. Our study document both 5
and 10 years lower risk of revision due to aseptic loosening for
uncemented vs cemented implants, which is in agreement with
previous ﬁndings11,28,34. The risk estimates for the period 2008e
2011 presented in Fig. 2(B) in relation to aseptic loosening are
affected by high uncertainty (since the aseptic loosening occurs
after a longer follow-up period) and should be interpreted with
caution.
Uncemented implants may be more resistant to aseptic loos-
ening but are more susceptible to revisions due to other causes,
including dislocations, fractures and infections. The differences in
the femoral head size and bearing surfaces used between cemented
and uncemented implants could not entire explain the association
we found. On the other hand, the potential difference in the use of
cross-linked poly liner with documented low revision rate due to
wear39 between ﬁxation types may affect our results. Unfortu-
nately, information on highly cross-linked polyethylene use wasTable V
The most commonly used cup-stem implant combinations within each ﬁxation
technique of THR
Fixation
technique
Cup e stem Manufacturer N (%)
Uncemented Trilogy e Bimetric Zimmer-Biomet 1352 (8.2%)
Mallory-Head-Bimetric Biomet 507 (3.1%)
Pinnacle-Corail DePuy 749 (4.6%)
Trilogy e Spotorno Zimmer-NMS 1105 (6.7%)
Other 11,676 (71.2%)
Total 16,407
Cemented Lubinus e Lubinus SP II Link 1782 (27.1%)
Charnley e Charnley DePuy 1023 (14.9%)
Exeter e Exeter Stryker 986 (15.0%)
Reﬂection e Spectron Smith & Nephew 270 (4.0%)
Other 2759 (40.4%)
Total 6824
Hybrid Trilogy e Spectron EF Zimmer-Smith &
Nephew
139 (4.5%)
Mallory Head e Exeter Biomet e Stryker 185 (6.1%)
Trilogy e Lubinus SP II Zimmer-Link 258 (8.4%)
Trilogy e Exeter Zimmer-Stryker 155 (5.0%)
Other 2204 (71.8%)
Total 3068
Inverse
Hybrid
Elite e Corail DePuy e DePuy 317 (9.7%)
Elite e ABG DePuy-Stryker 217 (6.7%)
Reﬂection e Corail Smith &
Nephew-DePuy
146 (4.5%)
Marathon e Corail DePuy 376 (11.5%)
Other 2202 (67.6%)
Total 3259not available in our dataset. The analyses from New Zealand
showed a higher revision rate for uncemented vs cemented im-
plants among all THR patients more than 90 days postoperatively
due to dislocations, pain, periprosthetic femoral fractures and other
causes, except deep infections11. Separate data on younger patients
were not available in their study. Another study from Finland on
patients less than 55 years of age foundmore dislocations, fractures
and revisions due to other reasons in uncemented than cemented
THRs34, in addition to higher wear of the polyethylene liner among
modular uncemented cups. A study based on Swedish data from
the period 1992e2007 found an increased fracture risk around
uncemented stems compared to cemented stems12. The increase in
early revision risk due to dislocations, fractures and deep infections
has been observed in many countries26e28. Several risk factors for
dislocation have been identiﬁed including small femoral head
size40,41 and posterior surgical approach42. Further research is
warranted to increase our understanding of the risk factors for
dislocations, fractures and deep infections. However, integration of
clinical expertise and evidence-based medicine including national
hip registry data into the decision-making process for patient care
to optimize clinical outcome remains a challenge. However, our
ﬁndings presented in Fig. 2(D) of no major difference in the risk of
revision due to any causewithin 2 years of surgery in the latest time
period when comparing different ﬁxation types might be prom-
ising. Still, there is a lot of work to be done to overcome short-term
problems of uncemented implants. A recent study, however, found
that uncemented implants are still associated with low cost effec-
tiveness when comparing improvement in health related
outcomes43.
Despite longer tradition of use of hybrid implant, a New Zealand
study among younger patients found comparable survival of hybrid
implants and cemented implants in relation to revision due to
aseptic loosening11, which is similar to our results. The results are
also found in the Australian hip registry36. Hybrid implants were
also in our study more susceptible to revision causes other than
aseptic loosening, may be because of problems related to the
uncemented cup component. The problem is not only short-term,
since analyses among patients with complete 5 and 10 years
follow up pointed up in the same direction. The slightly higher
revision risk of on inverse hybrid compared with cemented was
also related to other revision than aseptic loosening. This ﬁnding
accords with previous reports of increased risk of early peri-
prosthetic fractures and infections using inverse hybrid
implants44,45.
Implants brands
Another interesting but concerning ﬁnding in our study is the
fact that about 70% of the THR patients received more than 100
different uncemented cup-stem implant combinations rather than
one of the most common combinations presented in Table III. It is
A.B. Pedersen et al. / Osteoarthritis and Cartilage 22 (2014) 659e667 665worrisome that the majority of combinations available on the
market have only been used in less than 100 operations during the
17 years long study period. Other registries reported thatmore than
70% of their new introduced implants was used in less than 100
cases which is a problem since about 30% of these implants had
higher revision rate compared to well established implants in the
same class and none of the implants performed better15,16. Low
number of observations and few revisions hampers conclusive
analyses of single combinations. The clinicians are familiar with
parts of the health technology assessment process in the context of
the introduction of new drugs and the phases I to IV of drug trial
development46. However, the assessment of novel surgical devices
has not quite reached the level of pharmacological trials. More than
two decades ago, stepwise introduction of new hip implants was
introduced with growing acceptance, including clinical trials,
radiostereometry, digitized radiography and a national hip regis-
try47. One may argue that implants used in a small number of op-
erations are in phase IV of a stepwise introduction. In addition, the
introduction of new implants involves aspects not known in drug
trials, such as surgeons needing to acquire new practical skills and
go through a “learning curve”, efﬁcacy vs effectiveness issues, and
cost-beneﬁt assessments of implants. The number of different
surgeons using speciﬁc implants and surgeon volume is variables
further needed to fully understand the size of the problem. How-
ever, it has been shown previously that low hospital volume affect
more survival of uncemented than cemented implants48 which
might be an extra argument for using cemented implants since they
are not so prone to technical error. The high number of implant
combinations on the market makes novelty of new implants
questionable. The validity of implant brands and combinations re-
ported to NARA is not fully known as only three of the four regis-
tries in NARA are using the catalog numbers to identify the
implants. This system, when fully implemented would in future
enable uniformly identiﬁcation and comparison of implant within-
and between countries.
Methodological considerations
We used the NARA dataset, which includes registry data from
four Scandinavian countries with well-documented registration
completeness and data validity17e19. By using the NARA database
we were able to obtain a sufﬁcient number of patients to get reli-
able risk estimates for revision. Still, we were not able to perform
detailed analyses on different implant brands and combinations.
Although we performed multivariate analyses controlling for some
confounders we cannot entirely exclude the impact of bias on our
estimates. For example, we did not have information on surgeon
volume which might explain some of our ﬁndings in relation to
higher early revision rates of uncemented and hybrid implants.
However, this information has merely been available in previous
studies on the same subject. Although patient and surgeon pref-
erences may be related to age and sex49, we have no reason to
believe that these preferences are related to ﬁxation technique in
this young patient population. The assumption of proportional
hazard was not fulﬁlled in Cox regression analyses for ﬁxation
technique which we partly dealt with splitting the follow-up
period. However we still reported the overall RR estimates being
very well aware that our risk estimates might be biased in order to
be able to compare our results with the results from other registries
using the same method.
In conclusion, in this large population-based study on younger
THR patients, risk of any revision was similar for uncemented and
cemented implants whereas it was higher for hybrid implants.
Uncemented implants perform better in relation to long-term risk
of aseptic loosening, whereas both uncemented and hybrid ratherthan cemented implants in patients younger than 55 years had
more short-term revisions because problems due to dislocation,
periprosthetic fracture and infection has not yet been completely
solved. The vast majority of implant combinations were used in
very few operations.
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